Biolife Solutions (BLFS) Amortization of Deferred Charges (2011 - 2023)

Biolife Solutions (BLFS) reported Amortization of Deferred Charges of $13000.0 for Q1 2023, down 27.78% quarter-over-quarter from $18000.0 in Q4 2022.

Biolife Solutions (BLFS) Amortization of Deferred Charges (2011 - 2023) Analysis & Trends

Biolife Solutions (BLFS) has 8 years of Amortization of Deferred Charges data on file, last reported at $13000.0 in Q1 2023.

  • Amortization of Deferred Charges for Q1 2023 came in at $13000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $13000.0 (down 27.78% YoY), and the FY2023 annual result was $13000.0, down 27.78% from the prior year.
  • Amortization of Deferred Charges retreated to $13000.0 in Q1 2023 per BLFS's latest filing, from $18000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $18000.0 in Q4 2022 and troughed at $13000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Biolife Solutions 1.27 Bn 1.19 Bn 17.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 13,000.00
Mar 31, 2023 13,000.00
Dec 31, 2022 18,000.00
Dec 31, 2022 18,000.00
Dec 31, 2016 181,984.00
Dec 31, 2016 181,984.00
Jun 30, 2016 86,736.00
Jun 30, 2016 86,736.00
Mar 31, 2016 -31,749.00
Mar 31, 2016 -31,749.00
Dec 31, 2015 31,750.00
Dec 31, 2015 31,750.00
Mar 31, 2015 -31,750.00
Mar 31, 2015 -31,750.00
Mar 31, 2014 13,022.00
Mar 31, 2014 13,022.00
Dec 31, 2013 -31,674.00
Dec 31, 2013 -31,674.00
Sep 30, 2013 14,263.00
Sep 30, 2013 14,263.00